Corey named associate at Smith, Gildea & Schmidt

Christopher W. Corey has been named an Associate at Smith, Gildea & Schmidt, where has served as a Law Clerk since January 2011.

Christopher W. Corey

A native of Cockeysville, Corey graduated from Louisiana State University in 2008 with a Bachelors Degree in Business Administration and Finance. In May 2013, he graduated Magna Cum Laude from the University of Maryland School of Law. Corey passed the Maryland Bar Exam and was sworn in by the Maryland Court of Appeals last month.

“We are very excited to have Chris join our firm. He is one of the nation’s top young lawyers and has already proven to be a great asset to our land use and real estate practice,” said David Gildea, Founder and Managing Partner of Smith, Gildea & Schmidt, a regional law firm based in Towson. “We look forward to him being a part of our team and growing along with the firm.”

Applefeld joins MSBA Construction Law Section Council

Adelberg, Rudow, Dorf & Hendler, LLC Member and Litigation Section Chair David B. Applefeld was appointed to serve on the Maryland State Bar Association Construction Law Section Council.

David B. Applefeld

With more than 22 years experience, Applefeld has litigated construction defect claims, insurance coverage claims, architectural and engineering professional negligence claims and business disputes in all levels of state and federal courts, before administrative agencies and before the American Arbitration Association.

He currently serves as national panel trial counsel and special litigation counsel for several insurance companies and businesses, and is a frequent speaker and author on insurance law, construction law and litigation topics.

In addition to co-chairing the Construction Subcommittee of the American Bar Association’s Insurance Coverage Litigation Committee, Applefeld is a member of the Association’s Tort and Insurance Practice Section (Product, General Liability and Construction Law Committee) and Forum on the Construction Industry.

He also is active in the Bar Association of Baltimore City, Baltimore County Bar Association, Defense Research Institute, Maryland Defense Counsel, Inc., Home Builders Association of Maryland and the American Subcontractors Association of Baltimore, Inc.

Applefeld earned a J.D., cum laude, from the University of Baltimore School of Law and a bachelor’s degree from the University of New Hampshire.

Founded in 1927, Adelberg, Rudow, Dorf & Hendler, LLC has offered experienced counsel to corporations, institutions, associations and individuals for more than 80 years. With offices in downtown Baltimore and Howard County, the firm concentrates in a diverse set of practice areas including business, banking, bankruptcy, commercial finance, family law, civil and criminal litigation, health care, white-collar criminal defense, real estate, construction, federal and state taxes, wills, estates and trusts, arbitration and mediation, and intellectual property. Visit for additional information.

Connolly named director of bioentrepreneurship at UM Ventures

COLLEGE PARK — University of Maryland Ventures (UM Ventures) announced today that Dr. Martha J. Connolly has been named director of bioentrepreneurship, a new program supported by the Maryland Technology Enterprise Institute (Mtech) and the A. James Clark School of Engineering, designed to enhance collaboration between the University of Maryland, College Park (UMD) and the University of Maryland, Baltimore (UMB) as part of the MPowering the State initiative.

Dr. Martha J. Connolly

“UM Ventures creates an integrated innovation ecosystem that includes entrepreneurial support resources,” said James Hughes, Chief Economic Development Officer and Vice President at UMB. “Experts like Martha help turn novel ideas into sustainable businesses, and I’m pleased to have her as part of our enterprise.”

Connolly joins the UM Ventures team whose goal is to foster entrepreneurship among faculty and students. She will lead the first-ever course in entrepreneurship on the UMB campus starting this month. Students from the schools of medicine, nursing, pharmacy, law, social work, dentistry and the UMB graduate school are eligible. Connolly is also working closely with 16 teams of engineering students from College Park who are paired with UMB clinical faculty to define problems in healthcare, then developing products to improve patient health and clinical outcomes. Increasingly, students look at careers beyond the traditional academic research path and these courses will prepare them for careers in private industry.

“Martha Connolly is a highly regarded and proven professional in technology-based economic development in the state of Maryland,” said University System of Maryland Chancellor William E. “Brit” Kirwan. “As one of the state’s first biotechnology advocates, she helped lay the foundation for the state’s now-thriving bioscience economy.”

Connolly has served as director of the Mtech Maryland Industrial Partnerships (MIPS) program since 2003. MIPS is a grant program that funds and connects Maryland companies with University System of Maryland faculty to develop commercially promising technology products.

As head of MIPS, where nearly 40 percent of funding is awarded to bioscience-related projects, Connolly connected faculty with companies such as MedImmune, CSA Medical, WellDoc, PharmAthene, GenVec, Innovative Biosensors, 20/20 Gene Systems, Alba Therapeutics, A&G Pharmaceutical and Gliknik to foster development of new products.

Previous to MIPS, Connolly directed business development activities at a publicly traded biopharmaceutical company, and co-founded a startup technology development and commercialization firm.

Before that, Connolly was the first-ever biotechnology advocate hired at the state level at the Maryland Department of Business and Economic Development (DBED) to foster the state’s then fledgling bioscience industry. During her time at DBED, she helped grow the Maryland bioscience community from 300 to 450 businesses.

Connolly was the first woman to graduate from The Johns Hopkins University’s biomedical engineering doctoral program and was among the first class of co-eds at the Stevens Institute of Technology.

Connolly worked on funded research from both the National Institutes of Health and the American Lung Association as a faculty member and director of an independent research laboratory at UMB for 11 years. She has authored 37 full-length, peer-reviewed publications in the area of cardiovascular systems physiology and bioengineering.

In 2007, the Daily Record named Connolly one of Maryland’s 50 Most Influential People. In 2010, she received the President’s Award from the Greater Baltimore Committee’s Bioscience Alliance. In 2013, she was elected a fellow of the American Institute of Medical and Biological Engineering.

About UM Ventures

UM Ventures is an initiative to channel the tremendous technical resources and research expertise of the University of Maryland, engaging partners in industry and social ventures to expand real world impact. By encouraging students and faculty, providing expert advice and business services, more discoveries will reach the market. By engaging directly with external partners UM Ventures brings new investment, expanded markets and more start-up ventures.

About MPowering the State

The University of Maryland: MPowering the State brings together two universities of distinction to form a new collaborative partnership. Harnessing the resources of each, the University of Maryland, College Park and the University of Maryland, Baltimore will focus the collective expertise on critical state-wide issues of public health, biomedical informatics, and bioengineering. This collaboration will drive an even greater impact on the state, its economy, the job market, and the next generation of innovators. The joint initiatives will have a profound effect on productivity, the economy, and the very fabric of higher education.


Chappell named General Manager, U.S. Affairs for MIMETAS

BioHealth Innovation, Inc. (BHI) and MIMETAS announced that Todd Chappell, MBA, an Entrepreneur-in-Residence for BHI, has been named General Manager, U.S. Affairs for MIMETAS. A Netherlands-based company, MIMETAS is establishing its offices within BHI’s headquarters in Rockville. MIMETAS and BHI created a U.S. subsidiary of MIMETAS to access the clinical, regulatory and scientific resources available in Central Maryland and to access the U.S. marketplace, the largest life sciences market in the world.

Todd Chappell

“We’re very pleased to add Todd to the MIMETAS team,” said Jos Joore, Ph.D., Chief Business Officer of MIMETAS. “Todd couples a vast experience in business creation with a profound understanding of biology and disease mechanisms. Most importantly, Todd shares our sense of urgency around enabling better medical treatment by using more predictive cell culture models.”

Previously, Mr. Chappell was the Vice President of Operations for Shape Pharmaceuticals, a portfolio company of HealthCare Ventures, LLC, where he oversaw all day-to-day operations involved in the development of a novel HDAC inhibitor for Cutaneous-T-Cell-Lymphoma. Prior to that, he was at CombinatoRx Inc. for eight years and served as Director of New Products. Mr. Chappell will be combining his role at MIMETAS with his existing EIR position at BHI.

“A U.S. market presence is of crucial importance to further expand the MIMETAS business model,” said Mr. Chappell. “The United States leads the way in driving enhanced models for development of new drugs and the MIMETAS Organ-on-a-Chip platform is an important option for early-stage drug development and later-stage therapy selection.”

MIMETAS’ OrganoPlatesTM contain 96 3D cell cultures that are each individually perfused with medium. The platform allows for arbitrary co-culture complexity without usage of artificial membranes and mimics gradients of signaling molecules similar to the human body. Moreover the microtiter plate platform is fully compatible to industrial screening and readout equipment.

“We identified MIMETAS as a high potential, fast-growing company,” said Rich Bendis, President & CEO of BHI. “The presence of MIMETAS in the state of Maryland is therefore mutually beneficial: it provides MIMETAS with access to top U.S. institutions such as Johns Hopkins University, University of Maryland, NIH, and FDA while the presence of MIMETAS here will help generate high-tech jobs in the state of Maryland.”

MIMETAS currently is looking to fill a business development role. This new position will establish and manage the U.S. subsidiary in collaboration with BHI. Further information is available on the BHI website.


MIMETAS develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. MIMETAS’ products are designed to offer increased predictive value as compared to laboratory animals and conventional cell culture models. The MIMETAS OrganoPlate™ platform allows 3D cell culture with continuous perfusion, membrane-free co-culture, boundary and gradient formation. In close collaboration with its customers, MIMETAS develops and validates customized disease, toxicology and transport models. Ultimately, MIMETAS will make its technology available for personalized therapy selection. Visit for more information.

About BioHealth Innovation, Inc.

BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at

# # #

Media contacts:

Rich Bendis, President & CEO, 301-637-6439,

Jos Joore, Chief Business Officer MIMETAS, +31 85 888 31 61,

Snyder appointed public relations specialist

Stevenson University has appointed Dave Snyder as public relations specialist in the Office of Marketing and Digital Communications.

Dave SnyderSnyder most recently worked as a staff writer with the Baltimore Jewish Times and previously as a sports editor for He has also had articles published in The Huffington Post and PressBox.

“Growing up in the area, I have watched Stevenson University develop tremendously,” Snyder said. “It is exciting to now be a part of the community and the culture at Stevenson as it continues to grow.”

In his role, Snyder will be responsible for sharing news about the campus, pitching the media, and supporting Stevenson’s online presence through social media and other outlets.

Snyder graduated from the University of Maryland, College Park in 2009 with a bachelor’s of arts in journalism with a minor in Spanish. He lives in Pikesville.

Monarch Academy Public Charter School names Baltimore campus after Melnick

Monarch Academy Public Charter School, which moved into its permanent home at 2525 Kirk Ave. in Baltimore City this fall with 1,000 students, has named its Baltimore campus the Melnick Campus. The naming of this campus recognizes the support of Jonathan Melnick, former chair of the National Children’s Guild Foundation.

Jonathan Melnick

Melnick made it financially feasible for Monarch Academy to purchase and renovate the former Coca-Cola building, which houses the school. In addition, Melnick has made a significant impact on revitalization efforts in the Coldstream-Homestead-Montebello neighborhood, where Monarch Academy is located.

“Monarch Academy is proud to be an anchor in the community as we partner with Jonathan and the community association to help improve the neighborhood. We thank Jonathan for all he has done to provide a permanent home for Monarch Academy Baltimore in this historic building, and we are very pleased to name our Baltimore Campus in his honor,” said Andrew Ross, president and CEO of The Children’s Guild, the sponsoring organization of Monarch Academy.